EQUITY TRANSACTIONS (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
| Equity [Abstract] |
|
| Schedule of warrant activity |
| Schedule of warrant activity | |
| | |
| | |
| | |
| |
| | |
Fiscal Year Ended March 31, | |
| | |
2026 | | |
2025 | |
| | |
Warrants | | |
Weighted Average Exercise Price | | |
Warrants | | |
Weighted Average Exercise Price | |
| Outstanding, beginning of year | |
| 235,712 | | |
$ | 35.55 | | |
| 409 | | |
$ | 200.90 | |
| Granted | |
| 1,955,126 | | |
$ | 5.36 | | |
| 361,550 | | |
$ | 35.80 | |
| Exercised | |
| (210,555 | ) | |
$ | 24.38 | | |
| (123,131 | ) | |
$ | 39.20 | |
| Cancelled/Forfeited | |
| (22,793 | ) | |
$ | 46.40 | | |
| (3,116 | ) | |
$ | 250.13 | |
| Outstanding, end of year | |
| 1,957,490 | | |
$ | 6.48 | | |
| 235,712 | | |
$ | 35.55 | |
| Exercisable, end of year | |
| 1,957,490 | | |
$ | 6.48 | | |
| 235,712 | | |
$ | 35.55 | |
| Weighted average estimated fair value of warrants granted | |
| | | |
$ | N/A | | |
| | | |
$ | N/A | |
|
| Schedule of warrant activity exercisable and outstanding |
| Schedule of warrant activity exercisable and outstanding | |
| | |
| | |
| |
| | |
Warrants Outstanding | |
Range of Exercise Prices | |
Number Outstanding | | |
Weighted Average Remaining Life (Years) | | |
Weighted Average Exercise Price | |
| $9.00 or Below | |
| 1,899,572 | | |
| 4.99 | | |
$ | 5.26 | |
| $46.40 | |
| 57,918 | | |
| 3.13 | | |
$ | 46.40 | |
| | |
| 1,957,490 | | |
| | | |
| | |
The detail of the warrants outstanding and exercisable as of March 31,
2025 is as follows:
| | |
| | |
| | |
| |
| | |
Warrants Outstanding and Exercisable | |
Range of Exercise Prices | |
Number Outstanding | | |
Weighted Average Remaining Life (Years) | | |
Weighted Average Exercise Price | |
| $46.4 or Below | |
| 235,712 | | |
| 4.63 | | |
$ | 35.50 | |
| | |
| 235,712 | | |
| | | |
| | |
|
| Schedule of options outstanding that have vested and are expected to vest |
| Schedule of options outstanding that have vested and are expected to
vest | |
| | |
| | |
| |
| | |
Number of Shares | | |
Weighted Average Exercise Price | | |
Weighted Average Remaining Contractual Term in Years | |
| Vested | |
| 659 | | |
$ | 1,305.04 | | |
| 5.12 | |
| Expected to vest | |
| – | | |
$ | – | | |
| – | |
| Total | |
| 659 | | |
| | | |
| | |
|
| Schedule of stock option activity |
| Schedule of stock option activity | |
| | |
| | |
| | |
| |
| | |
Fiscal Year Ended March 31, | |
| | |
2026 | | |
2025 | |
| | |
Options | | |
Weighted Average Exercise Price | | |
Options | | |
Weighted Average Exercise Price | |
| Outstanding, beginning of year | |
| 659 | | |
$ | 1,305.04 | | |
| 1,086 | | |
$ | 1,462.20 | |
| Granted | |
| – | | |
$ | – | | |
| – | | |
$ | – | |
| Cancelled/Forfeited | |
| – | | |
$ | – | | |
| (427 | ) | |
$ | 1,702.90 | |
| Outstanding, end of year | |
| 659 | | |
$ | 1,305.04 | | |
| 659 | | |
$ | 1,305.04 | |
| Exercisable, end of year | |
| 659 | | |
$ | 1,305.04 | | |
| 583 | | |
$ | 1,328.20 | |
| Weighted average estimated fair value of options granted | |
| | | |
$ | N/A | | |
| | | |
$ | N/A | |
|
| Schedule of nonvested shares |
| Schedule of nonvested shares | |
| | |
| |
| | |
Shares | | |
Weighted Average Grant Date Fair Value | |
| Nonvested stock options at April 1, 2025 | |
| 76 | | |
$ | 1.37 | |
| Vested | |
| (76 | ) | |
$ | 1.37 | |
| Forfeited | |
| – | | |
$ | – | |
| Nonvested stock options at March 31, 2026 | |
| – | | |
| | |
|
| Schedule of detail of options outstanding and exercisable by exercise price |
| Schedule of detail of options outstanding and exercisable by exercise
price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Options Outstanding |
|
|
Options Exercisable |
|
| Exercise Prices |
|
Number
Outstanding |
|
|
Weighted
Average
Remaining
Life (Years) |
|
|
Weighted
Average
Exercise
Price |
|
|
Number
Outstanding |
|
|
Weighted
Average
Exercise
Price |
|
| $1024.00-1,128.00 |
|
|
507 |
|
|
|
6.22 years |
|
|
$ |
1,092.00 |
|
|
|
431 |
|
|
$ |
1,085.00 |
|
| $2,016.00 |
|
|
152 |
|
|
|
5.76 years |
|
|
$ |
2,016.00 |
|
|
|
152 |
|
|
$ |
2,016.00 |
|
| Total |
|
|
659 |
|
|
|
|
|
|
|
|
|
|
|
583 |
|
|
|
|
|
|
| Schedule of RSUs |
| Schedule of RSUs | |
| |
| | |
Shares | |
| Nonvested RSUs at April 1, 2025 | |
| – | |
| Granted | |
| 7,143 | |
| Vested | |
| (7,143 | ) |
| Nonvested RSUs at March 31, 2026 | |
| – | |
|
| Schedule of stock-based compensation |
| Schedule of stock-based compensation | |
| | |
| |
| | |
Fiscal Year Ended | |
| | |
March 31, 2026 | | |
March 31, 2025 | |
| Vesting of restricted stock units | |
$ | 200,000 | | |
$ | 218,750 | |
| Vesting of stock options | |
| 78,547 | | |
| 196,484 | |
| Total Stock-Based Compensation | |
$ | 278,547 | | |
$ | 415,234 | |
|